Cargando…
Drug design with Cdc7 kinase: a potential novel cancer therapy target
Identification of novel molecular targets is critical in development of new and efficient cancer therapies. Kinases are one of the most common drug targets with a potential for cancer therapy. Cell cycle progression is regulated by a number of kinases, some of which are being developed to treat canc...
Autores principales: | Sawa, Masaaki, Masai, Hisao |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2761190/ https://www.ncbi.nlm.nih.gov/pubmed/19920912 |
Ejemplares similares
-
Cdc7 kinase stimulates Aurora B kinase in M-phase
por: Ito, Sayuri, et al.
Publicado: (2019) -
Claspin recruits Cdc7 kinase for initiation of DNA replication in human cells
por: Yang, Chi-Chun, et al.
Publicado: (2016) -
Deregulated Cdc6 inhibits DNA replication and suppresses Cdc7-mediated phosphorylation of Mcm2–7 complex
por: Kundu, Lena R., et al.
Publicado: (2010) -
Cdc7 activates replication checkpoint by phosphorylating the Chk1-binding domain of Claspin in human cells
por: Yang, Chi-Chun, et al.
Publicado: (2019) -
ATR–Chk1–APC/C(Cdh1)-dependent stabilization of Cdc7–ASK (Dbf4) kinase is required for DNA lesion bypass under replication stress
por: Yamada, Masayuki, et al.
Publicado: (2013)